These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 14971029)
1. Aggregation of MHC class I molecules on a CD8+ alphabeta T cell clone specifically inhibits non-antigen-specific lysis of target cells. Caparrós E; de Heredia AB; Carpio E; Sancho D; Aguado E; Aparicio P Eur J Immunol; 2004 Jan; 34(1):47-55. PubMed ID: 14971029 [TBL] [Abstract][Full Text] [Related]
2. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells. Lafarge X; Pitard V; Ravet S; Roumanes D; Halary F; Dromer C; Vivier E; Paul P; Moreau JF; Déchanet-Merville J Eur J Immunol; 2005 Jun; 35(6):1896-905. PubMed ID: 15864777 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547 [TBL] [Abstract][Full Text] [Related]
4. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295 [TBL] [Abstract][Full Text] [Related]
6. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures. Das A; Saxena RK Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968 [TBL] [Abstract][Full Text] [Related]
7. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha. Jewett A; Bonavida B Clin Immunol; 2000 Jul; 96(1):19-28. PubMed ID: 10873424 [TBL] [Abstract][Full Text] [Related]
8. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Dembic Z; Hofgaard PO; Omholt H; Bogen B Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083 [TBL] [Abstract][Full Text] [Related]
9. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I. von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431 [TBL] [Abstract][Full Text] [Related]
10. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. Gunturi A; Berg RE; Crossley E; Murray S; Forman J Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583 [TBL] [Abstract][Full Text] [Related]
11. A divalent human leukocyte antigen-B7 fusion-protein up-regulates CD25 and CD69 in alloreactive CD8+ T cells bypassing CD28 costimulation. Rickert U; Welke J; Behrens D; Zavazava N Transplantation; 2006 May; 81(9):1337-44. PubMed ID: 16699464 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687 [TBL] [Abstract][Full Text] [Related]
13. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha. Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961 [TBL] [Abstract][Full Text] [Related]
14. Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Jabri B; Ebert E Immunol Rev; 2007 Feb; 215():202-14. PubMed ID: 17291290 [TBL] [Abstract][Full Text] [Related]
15. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity. Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732 [TBL] [Abstract][Full Text] [Related]
16. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612 [TBL] [Abstract][Full Text] [Related]
17. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit. Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668 [TBL] [Abstract][Full Text] [Related]
18. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I. Rabinovich BA; Li J; Hurren R; Miller RG Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925 [TBL] [Abstract][Full Text] [Related]
19. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex. Rubin B; Riond J; Leghait J; Gairin JE Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695 [TBL] [Abstract][Full Text] [Related]
20. Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines. Rubio G; Férez X; Sánchez-Campillo M; Gálvez J; Martí S; Verdú R; Hernández-Caselles T; García-Peñarrubia P J Leukoc Biol; 2004 Jul; 76(1):116-24. PubMed ID: 15123774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]